M. Gariboldi, P. Tutka, R. Samanin, and A. Vezzani, Stimulation of 5-HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats, British Journal of Pharmacology, vol.114, issue.5, pp.813-821, 1996.
DOI : 10.1111/j.1476-5381.1996.tb15745.x

K. Gerber, J. Filakovszky, P. Halasz, and G. Bagdy, The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy, Brain Research, vol.807, issue.1-2, pp.243-248, 1998.
DOI : 10.1016/S0006-8993(98)00801-4

N. Ginovart, W. Hassoun, L. Bars, D. Weissmann, D. Leviel et al., In vivo characterization of p-[(18)f]mppf, a fluoro analog of way-100635 for visualization of, p.5

G. Giovacchini, M. T. Toczek, R. Bonwetsch, A. Bagic, L. Lang et al., 5-ht 1a receptors are reduced in temporal lobe epilepsy after partial-volume correction, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol.46, pp.1128-1163, 2005.

M. Graf, R. Jakus, S. Kantor, G. Levay, and G. Bagdy, Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy, Neuroscience Letters, vol.359, issue.1-2, pp.45-53, 2004.
DOI : 10.1016/j.neulet.2004.01.072

M. Guenot, J. Isnard, P. Ryvlin, C. Fischer, K. Ostrowsky et al., Neurophysiological Monitoring for Epilepsy Surgery: The Talairach SEEG Method, Stereotactic and Functional Neurosurgery, vol.77, issue.1-4
DOI : 10.1159/000064595

. Stereoelectroencephalography, Indications, results, complications and therapeutic applications in a series of 100 consecutive cases, Stereotact Funct Neurosurg, vol.77, pp.29-32, 2001.

O. Houdé, B. Mazoyer, and N. Tzourio-mazoyer, Cerveau et psychologie, introduction à l'imagerie cérébrale anatomique, 2002.

D. Hoyer, J. P. Hannon, and G. R. Martin, Molecular, pharmacological and functional diversity of 5-HT receptors, Pharmacology Biochemistry and Behavior, vol.71, issue.4, pp.533-54, 2002.
DOI : 10.1016/S0091-3057(01)00746-8

D. Hoyer and G. Martin, 5-HT Receptor Classification and Nomenclature: Towards a Harmonization with the Human Genome, Neuropharmacology, vol.36, issue.4-5, pp.419-447, 1997.
DOI : 10.1016/S0028-3908(97)00036-1

P. P. Humphrey, P. Hartig, and D. Hoyer, A proposed new nomenclature for 5-HT receptors, Trends in Pharmacological Sciences, vol.14, issue.6
DOI : 10.1016/0165-6147(93)90016-D

R. Jakus, M. Graf, G. Juhasz, K. Gerber, G. Levay et al., 5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike???wave discharges in a genetic rat model of absence epilepsy, Experimental Neurology, vol.184, issue.2, pp.964-72, 2003.
DOI : 10.1016/S0014-4886(03)00352-2

P. C. Jobe, A. L. Picchioni, and L. Chin, Role of brain 5-hydroxytryptamine in audiogenic seizure in the rat, Life Sciences, vol.13, issue.1, pp.1-13, 1973.
DOI : 10.1016/0024-3205(73)90271-3

J. E. Jones, B. P. Hermann, J. J. Barry, F. Gilliam, A. M. Kanner et al., Clinical Assessment of Axis I Psychiatric Morbidity in Chronic Epilepsy: A Multicenter Investigation, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.17, issue.2, pp.172-181, 2005.
DOI : 10.1176/jnp.17.2.172

C. Juhasz, D. C. Chugani, O. Muzik, A. Shah, E. Asano et al., Alphamethyl-l-tryptophan pet detects epileptogenic cortex in children with intractable epilepsy

C. Juhasz, D. C. Chugani, O. Muzik, C. Watson, J. Shah et al., Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy, Neurology, vol.55, issue.6, pp.825-860, 2000.
DOI : 10.1212/WNL.55.6.825

K. Kagawa, D. C. Chugani, E. Asano, C. Juhasz, O. Muzik et al., Epilepsy Surgery Outcome in Children With Tuberous Sclerosis Complex Evaluated With ??-[11C]Methyl-L-Tryptophan Positron Emission Tomography (PET), Journal of Child Neurology, vol.56, issue.7, pp.429-467, 2005.
DOI : 10.1177/08830738050200050701

P. Kahane, E. Landre, L. Minotti, S. Francione, and P. Ryvlin, The bancaud and talairach view on the epileptogenic zone: A working hypothesis, Epileptic Disord, vol.8, issue.2, pp.16-26, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00388256

A. M. Kanner, Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment, Biological Psychiatry, vol.54, issue.3, pp.388-98, 2003.
DOI : 10.1016/S0006-3223(03)00469-4

M. Kilian and H. Frey, Central monoamines and convulsive thresholds in mice and rats, Neuropharmacology, vol.12, issue.7
DOI : 10.1016/0028-3908(73)90121-4

Y. K. Kim, D. S. Lee, S. K. Lee, S. K. Kim, C. K. Chung et al., Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: Quantitative analysis of (18)f-fdg pet using spm, J Nucl Med, vol.44, pp.1006-1018, 2003.

S. Knake, E. Halgren, H. Shiraishi, K. Hara, H. M. Hamer et al., The value of multichannel MEG and EEG in the presurgical evaluation of 70 epilepsy patients, Epilepsy Research, vol.69, issue.1, pp.80-86, 2006.
DOI : 10.1016/j.eplepsyres.2006.01.001

M. J. Koepp, A. Hammers, C. Labbe, F. G. Woermann, D. J. Brooks et al., 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI, Neurology, vol.54, issue.2, pp.332-341, 2000.
DOI : 10.1212/WNL.54.2.332

M. J. Koepp, K. S. Hand, C. Labbe, M. P. Richardson, W. Van-paesschen et al., H] flumazenil autoradiography in hippocampal sclerosis, Annals of Neurology, vol.35, issue.5, pp.618-644, 1998.
DOI : 10.1002/ana.410430510

M. J. Koepp, M. P. Richardson, D. J. Brooks, and J. S. Duncan, Focal cortical release of endogenous opioids during reading induced seizures, The Lancet, vol.352, issue.9132, pp.952-957, 1998.
DOI : 10.1016/S0140-6736(97)09077-6

M. J. Koepp, M. P. Richardson, C. Labbe, D. J. Brooks, V. J. Cunningham et al., 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy, Neurology, vol.49, issue.3, pp.764-73, 1997.
DOI : 10.1212/WNL.49.3.764

H. F. Kung, D. A. Stevenson, Z. P. Zhuang, M. P. Kung, D. Frederick et al., Short Communication New 5-HT1A receptor antagonist: [3H]p-MPPF, Synapse, vol.23, issue.4, pp.344-350, 1996.
DOI : 10.1002/(SICI)1098-2396(199608)23:4<344::AID-SYN13>3.0.CO;2-X

L. Bars, D. Lemaire, C. Ginovart, N. Plenevaux, A. Aerts et al., High-yield radiosynthesis and preliminary in vivo evaluation of p-[18f]mppf, a fluoro analog of way- 100635. Nuclear medicine and biology, pp.343-50, 1998.

J. D. Leander, Fluoxetine, a Selective Serotonin-Uptake Inhibitor, Enhances the Anticonvulsant Effects of Phenytoin, Carbamazepine, and Ameltolide (LY 201116), Epilepsia, vol.46, issue.3, pp.573-579, 1992.
DOI : 10.1007/BF00431733

J. S. Lee, C. Juhasz, A. K. Kaddurah, and H. T. Chugani, Patterns of Cerebral Glucose Metabolism in Early and Late Stages of Rasmussen's Syndrome, Journal of Child Neurology, vol.16, issue.11, pp.798-805, 2001.
DOI : 10.1177/08830738010160110401

M. Lerner-natoli, Serotonin and Kindling Development, International Journal of Neuroscience, vol.36, issue.3, pp.139-51, 1987.
DOI : 10.3109/00207458709058789

K. T. Lu and P. W. Gean, Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation, Neuroscience, vol.86, issue.3, pp.729-766, 1998.
DOI : 10.1016/S0306-4522(98)00106-7

M. Luby, D. D. Spencer, J. H. Kim, N. Mccarthy, and G. , Hippocampal MRI volumetrics and temporal lobe substrates in medial temporal lobe epilepsy, Magnetic Resonance Imaging, vol.13, issue.8, pp.1065-71, 1995.
DOI : 10.1016/0730-725X(95)02014-K

H. Luders and I. Awad, Conceptual considerations; in Epilepsy surgery, pp.51-62, 1991.

H. O. Luders, I. Najm, D. Nair, P. Widdess-walsh, and W. Bingman, The epileptogenic zone, Epileptic Disord, vol.8, issue.2, pp.1-9, 2006.
DOI : 10.3109/9780203091708-114

F. Mauguiere and P. Ryvlin, The role of pet in presurgical assessment of partial epilepsies, Epileptic Disord, vol.6, pp.193-215, 2004.

S. Prendiville and K. Gale, Anticonvulsant Effect of Fluoxetine on Focally Evoked Limbic Motor Seizures in Rats, Epilepsia, vol.51, issue.2, pp.381-385, 1993.
DOI : 10.1016/0091-3057(85)90067-X

M. C. Prevett, V. J. Cunningham, D. J. Brooks, D. R. Fish, and J. S. Duncan, Opiate receptors in idiopathic generalised epilepsy measured with [11C]diprenorphine and positron emission tomography, Epilepsy Research, vol.19, issue.1, pp.71-78, 1994.
DOI : 10.1016/0920-1211(94)90090-6

M. Rapport, Serum vasoconstrictor (serotonin) the presence of creatinine in the complex; a proposed structure of the vasoconstrictor principle, J Biol Chem, vol.180, pp.961-970, 1949.

M. Rapport, A. Green, and I. Page, Crystalline Serotonin, Science, vol.108, issue.2804, pp.329-359, 1948.
DOI : 10.1126/science.108.2804.329

F. Rosenow and H. Luders, Presurgical evaluation of epilepsy, Brain, vol.124, issue.9, pp.1683-700, 2001.
DOI : 10.1093/brain/124.9.1683

P. Ryvlin, S. Bouvard, L. Bars, D. Mauguiere, and F. , Transient and falsely lateralizing flumazenil-PET asymmetries in temporal lobe epilepsy, Neurology, vol.53, issue.8, pp.1882-1887, 1999.
DOI : 10.1212/WNL.53.8.1882

P. Ryvlin and P. Kahane, The hidden causes of surgery-resistant temporal lobe epilepsy: extratemporal or temporal plus? editorial review, Current Opinion in Neurology, vol.18, issue.2, pp.125-132, 2005.
DOI : 10.1097/01.wco.0000162852.22026.6f

P. Ryvlin, B. Philippon, L. Cinotti, J. C. Froment, L. Bars et al., Tc-HMPAO-SPECT, Annals of Neurology, vol.31, issue.suppl, pp.650-656, 1992.
DOI : 10.1002/ana.410310613

P. Ryvlin and S. Rheims, Epilepsy surgery: Eligibility criteria and presurgical evaluation, Dialogues Clin Neurosci, vol.10, pp.91-103, 2008.

D. Salgado-commissariat and K. A. Alkadhi, Serotonin inhibits epileptiform discharge by activation of 5-HT1A receptors in CA1 pyramidal neurons, Neuropharmacology, vol.36, issue.11-12, pp.1705-1717, 1997.
DOI : 10.1016/S0028-3908(97)00134-2

P. A. Sargent, K. H. Kjaer, C. J. Bench, E. A. Rabiner, C. Messa et al., Brain serotonin1a receptor binding measured by positron emission tomography with

I. Savic, G. Blomqvist, C. Halldin, J. E. Litton, and B. Gulyas, C]flumazenil binding after epilepsy surgery, Acta Neurologica Scandinavica, vol.11, issue.Suppl. 2, pp.279-86, 1998.
DOI : 10.1111/j.1600-0404.1998.tb05953.x

I. Savic, P. Lindstrom, B. Gulyas, C. Halldin, B. Andree et al., Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy, Neurology, vol.62, issue.8, pp.1343-51, 2004.
DOI : 10.1212/01.WNL.0000123696.98166.AF

I. Savic, E. Svanborg, and J. O. Thorell, Cortical Benzodiazepine Receptor Changes are Related to Frequency of Partial Seizures: A Positron Emission Tomography Study, Epilepsia, vol.44, issue.3, pp.236-280, 1996.
DOI : 10.1016/0014-2999(92)90239-Z

D. Schmitz, T. Gloveli, R. M. Empson, A. Draguhn, and U. Heinemann, Serotonin reduces synaptic excitation in the superficial medial entorhinal cortex of the rat via a presynaptic mechanism, The Journal of Physiology, vol.11, issue.1, pp.119-148, 1998.
DOI : 10.1111/j.1469-7793.1998.119br.x

J. Schramm, Temporal lobe epilepsy surgery and the quest for optimal extent of resection: A review, Epilepsia, vol.37, issue.Pt 3, pp.1296-307, 2008.
DOI : 10.1111/j.1528-1167.2008.01604.x

S. U. Schuele and H. O. Luders, Intractable epilepsy: management and therapeutic alternatives, The Lancet Neurology, vol.7, issue.6
DOI : 10.1016/S1474-4422(08)70108-X

C. Y. Shiue, G. G. Shiue, P. D. Mozley, M. P. Kung, Z. P. Zhuang et al., p-[18F]-MPPF: A potential radioligand for PET studies of 5-HT1A receptors in humans, Synapse, vol.25, issue.2, pp.147-54, 1997.
DOI : 10.1002/(SICI)1098-2396(199702)25:2<147::AID-SYN5>3.0.CO;2-C

E. Trevathan, Does temporal lobe epilepsy surgery in children improve functional outcomes?, Nature Clinical Practice Neurology, vol.128, issue.3
DOI : 10.1038/ncpneuro0131

S. Goldman, Comparative study of hippocampal neuronal loss and in vivo binding of 5-ht1a receptors in the ka model of limbic epilepsy in the rat, Epilepsy Res, vol.47, pp.127-166, 2001.

Y. Wada, H. Hasegawa, M. Nakamura, and N. Yamaguchi, Serotonergic Inhibition of Limbic and Thalamic Seizures in Cats, Neuropsychobiology, vol.25, issue.2, pp.87-90, 1992.
DOI : 10.1159/000118813

Y. Wada, M. Nakamura, H. Hasegawa, and N. Yamaguchi, Intra-hippocampal injection of 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats, Neuroscience Letters, vol.159, issue.1-2, pp.179-82, 1993.
DOI : 10.1016/0304-3940(93)90828-9

Y. Wada, J. Shiraishi, M. Nakamura, and H. Hasegawa, Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats, Psychopharmacology, vol.252, issue.12, suppl B
DOI : 10.1007/BF02245959

H. Wakamoto, D. C. Chugani, C. Juhasz, O. Muzik, W. J. Kupsky et al., Alpha-Methyl-l-Tryptophan Positron Emission Tomography in Epilepsy With Cortical Developmental Malformations, Pediatric Neurology, vol.39, issue.3, pp.181-189, 2008.
DOI : 10.1016/j.pediatrneurol.2008.05.014

K. Watanabe, Y. Minabe, C. R. Ashby, . Jr, and H. Katsumori, Effect of acute administration of various 5-HT receptor agonists on focal hippocampal seizures in freely moving rats, European Journal of Pharmacology, vol.350, issue.2-3, pp.181-189, 1998.
DOI : 10.1016/S0014-2999(98)00255-6

J. P. Welsh, D. G. Placantonakis, S. I. Warsetsky, R. G. Marquez, L. Bernstein et al., The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity

S. Wiebe, W. T. Blume, J. P. Girvin, and M. Eliasziw, A Randomized, Controlled Trial of Surgery for Temporal-Lobe Epilepsy, New England Journal of Medicine, vol.345, issue.5, pp.311-319, 2001.
DOI : 10.1056/NEJM200108023450501

S. Wiebe and N. Jette, Conclusion:, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, vol.43, issue.04, pp.365-71, 2006.
DOI : 10.1227/00006123-199511000-00019

P. D. Williamson, J. A. French, V. M. Thadani, J. H. Kim, R. A. Novelly et al., Characteristics of medial temporal lobe epilepsy: Ii. Interictal and ictal scalp